Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03224845
Other study ID # 1022588
Secondary ID
Status Not yet recruiting
Phase N/A
First received July 18, 2017
Last updated July 24, 2017
Start date September 2017
Est. completion date September 2020

Study information

Verified date July 2017
Source Nova Scotia Health Authority
Contact Barbara Pavlova, PhD DClinPsy RPsych
Phone 902 473 2585
Email barbara.pavlova@dal.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Anxiety disorders usually start in childhood and adolescence and are associated with social and occupational difficulties in adulthood. Children who have a parent with an anxiety disorder and who find new situations distressing and avoid them are at an increased risk for developing an anxiety disorder. Research suggests that anti-anxiety parenting can help children grow up courageous and calm. It is, however, difficult to parent in an anti-anxiety way when the parent has an anxiety disorder himself or herself.

This research study will test the efficacy of a new program designed to prevent the onset or persistence of anxiety disorders in children at risk for anxiety disorders. The investigators will first help parents learn skills to cope with their own anxiety and then coach them to share these skills with their children and parent in an anti-anxiety way. The goal is to intervene early enough in the children's lives so that they can be free of anxiety disorders and lead happy, healthy and productive lives in adulthood.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 88
Est. completion date September 2020
Est. primary completion date September 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Parents:

Inclusion criteria:

Parents will be included if they have a current diagnosis of at least one anxiety disorder, one or more children between the ages two and eight years in their own care, capacity to provide informed consent, and ability to speak English well enough to benefit from the intervention.

Exclusion criteria:

Exclusion criteria for parents are receipt of an adequate course (6 or more sessions) of structured psychological therapy in the past 12 months, or plans to move out of Nova Scotia within the next three years. We will include parents with co-morbid mood disorders. However, those whose mood disorder is the primary complaint will be referred for treatment for their mood before being re-assessed. We will exclude parents with disorders that would interfere with the standard treatment protocol delivery; these include lifetime schizophrenia, autism, intellectual disability and current drug and alcohol use disorder.

Offspring:

Inclusion criteria:

Children are eligible if they are aged two to eight and if they have a score of inhibited temperament (negative emotionality) one standard deviation or more above the mean of an age-matched normative sample on the Laboratory Assessment of Temperament.

Exclusion criteria:

Those with lifetime schizophrenia, autism, general intellectual disability, and current drug and alcohol addiction will be excluded, as these conditions would impact on the standard delivery of the parenting intervention. We will exclude children currently receiving treatment for anxiety.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive behavioural skills training
The intervention will be delivered in two stages: First, the parent with an anxiety disorder will attend between six and sixteen weekly sessions of cognitive behavioural skills training focusing on their own anxiety. They will work on developing behaviours that will help them become less anxious in the long-run and on learning to evaluate danger in a realistic way. Next, the parent will take part in four to eight weekly sessions of anti-anxiety parenting skills training aiming to help them transfer the skills that they learned into parenting their children. In the parenting intervention, the parents will be guided to gradually expose their children to new situations, build communication skills and confidence, in addition to general parenting skills and principles.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Barbara Pavlova

Outcome

Type Measure Description Time frame Safety issue
Primary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of anxiety disorder in the offspring One year post randomization
Primary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of anxiety disorder in the offspring Two years post randomization
Primary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of anxiety disorder in the offspring Three years post randomization
Primary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of anxiety disorder in the offspring Five years post randomization
Primary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of anxiety disorder in the offspring Seven years post randomization
Primary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of anxiety disorder in the offspring Ten years post randomization
Secondary Teaching Task Battery Parenting behaviours One year post randomization
Secondary Teaching Task Battery Parenting behaviours Two years post randomization
Secondary Structured Clinical Interview for DSM-5 diagnoses (SCID-5) Diagnosis of anxiety disorder in the parent One year post randomization
Secondary Structured Clinical Interview for DSM-5 diagnoses (SCID-5) Diagnosis of anxiety disorder in the parent Two years post randomization
Secondary Laboratory Temperament Assessment Battery Temperament in the offspring One year post randomization
Secondary Laboratory Temperament Assessment Battery Temperament in the offspring Two years post randomization
Secondary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of major mood and psychotic disorders in offspring Three years post randomization
Secondary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of major mood and psychotic disorders in offspring Five years post randomization
Secondary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of major mood and psychotic disorders in offspring Seven years post randomization
Secondary Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) Diagnosis of major mood and psychotic disorders in offspring Ten years post randomization
Secondary Global Assessment of Functioning Functioning in the offspring One year post randomization
Secondary Global Assessment of Functioning Functioning in the offspring Two years post randomization
Secondary Global Assessment of Functioning Functioning in the offspring Three years post randomization
Secondary Global Assessment of Functioning Functioning in the offspring Five years post randomization
Secondary Global Assessment of Functioning Functioning in the offspring Seven years post randomization
Secondary Global Assessment of Functioning Functioning in the offspring Ten years post randomization
Secondary Screen for Child Anxiety Related Disorders Anxiety in the offspring - continuous One year post randomization
Secondary Screen for Child Anxiety Related Disorders Anxiety in the offspring - continuous Two years post randomization
Secondary Screen for Child Anxiety Related Disorders Anxiety in the offspring - continuous Three years post randomization
Secondary Screen for Child Anxiety Related Disorders Anxiety in the offspring - continuous Five years post randomization
Secondary Screen for Child Anxiety Related Disorders Anxiety in the offspring - continuous Seven years post randomization
Secondary Screen for Child Anxiety Related Disorders Anxiety in the offspring - continuous Ten years post randomization
Secondary Spence Children's Anxiety Scale Anxiety in the offspring - continuous One year post randomization
Secondary Spence Children's Anxiety Scale Anxiety in the offspring - continuous Two years randomization
Secondary Spence Children's Anxiety Scale Anxiety in the offspring - continuous Three years post randomization
Secondary Spence Children's Anxiety Scale Anxiety in the offspring - continuous Five years post randomization
See also
  Status Clinical Trial Phase
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Completed NCT02096783 - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer N/A
Completed NCT02145429 - Preventing Depression in Late Life: A Model for Low and Middle Income Countries N/A
Completed NCT00794456 - Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety Phase 3
Terminated NCT00896467 - Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy N/A
Completed NCT00252343 - Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder Phase 3
Not yet recruiting NCT05867823 - OcupApp: Occupational Self-analysis Intervention Through an Mobile Application N/A
Recruiting NCT04562324 - Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder N/A
Recruiting NCT05989451 - Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders N/A
Not yet recruiting NCT05488418 - Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56 N/A
Not yet recruiting NCT03608449 - Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System N/A
Completed NCT03400397 - An Effectiveness Study of the Cool Kids Programme N/A
Completed NCT00025844 - Fear Conditioning Using Computer-Generated Virtual Reality N/A
Completed NCT02579928 - Ketamine Infusion for Adolescent Depression and Anxiety Phase 4
Completed NCT02270073 - The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study N/A
Terminated NCT03764644 - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders N/A
Completed NCT01425619 - The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests N/A
Completed NCT01721824 - The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders N/A
Completed NCT01227980 - Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^ Phase 2
Completed NCT01764789 - Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer N/A